Phacilitate Leaders Forum

Phacilitate Leaders Europe Agenda 2018


Q&A: Regional case study: China. What is their stance on GMP regulatory guidelines?

Shared workshops
  • Do these new European GMP guidelines make it easier to work with other regions?
  • How do they view working with European ATMP biotechs/academic centres now these new legislations are in place?
Qinhua Cindy Ru, Managing Director - CRC Oncology
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd